AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
ROLE OF THE PINEAL-GLAND IN THE CONTROL OF MACROPHAGE FUNCTIONS AND ITS POSSIBLE IMPLICATION IN CANCER - A STUDY OF INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND THE PINEAL HORMONE MELATONIN
Authors: LISSONI P BARNI S TANCINI G BRIVIO F TISI E ZUBELEWICZ B BRACZKOWSKI R
Citation: P. Lissoni et al., ROLE OF THE PINEAL-GLAND IN THE CONTROL OF MACROPHAGE FUNCTIONS AND ITS POSSIBLE IMPLICATION IN CANCER - A STUDY OF INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 126-129
A STUDY OF INTERACTIONS AMONG MARKERS OF MACROPHAGE FUNCTIONS IN METASTATIC SOLID TUMORS - NEOPTERIN LEVELS IN RELATION TO THOSE OF TUMOR-NECROSIS-FACTOR-ALPHA AND OF SOLUBLE INTERLEUKIN-2 RECEPTORS
Authors: LISSONI P BRIVIO F FUMAGALLI L GALIMBERTI C CATALDO M MARSILI MT BRIVIO O BARNI S TANCINI G ANGELINI A
Citation: P. Lissoni et al., A STUDY OF INTERACTIONS AMONG MARKERS OF MACROPHAGE FUNCTIONS IN METASTATIC SOLID TUMORS - NEOPTERIN LEVELS IN RELATION TO THOSE OF TUMOR-NECROSIS-FACTOR-ALPHA AND OF SOLUBLE INTERLEUKIN-2 RECEPTORS, Journal of biological regulators and homeostatic agents, 8(1), 1994, pp. 32-35
SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I IN OPERABLE BREAST-CANCER IN RELATION TO THE MAIN PROGNOSTIC VARIABLES AND THEIR PERIOPERATIVECHANGES IN RELATION TO THOSE OF PROLACTIN
Authors: BARNI S LISSONI P BRIVIO F FUMAGALLI L MERLINI D CATALDO M ROVELLI F TANCINI G
Citation: S. Barni et al., SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I IN OPERABLE BREAST-CANCER IN RELATION TO THE MAIN PROGNOSTIC VARIABLES AND THEIR PERIOPERATIVECHANGES IN RELATION TO THOSE OF PROLACTIN, Tumori, 80(3), 1994, pp. 212-215
ASYMMETRICAL RESPONSE OF SEMICONDUCTOR-LASERS IN OPTICAL-SYSTEMS
Authors: BRIVIO F MAZZOLENI S MILANI M
Citation: F. Brivio et al., ASYMMETRICAL RESPONSE OF SEMICONDUCTOR-LASERS IN OPTICAL-SYSTEMS, Theoretical and mathematical physics, 99(3), 1994, pp. 648-652
EFFICACY OF THE CONCOMITANT ADMINISTRATION OF THE PINEAL HORMONE MELATONIN IN CANCER-IMMUNOTHERAPY WITH LOW-DOSE IL-2 IN PATIENTS WITH ADVANCED SOLID TUMORS WHO HAD PROGRESSED ON IL-2 ALONE
Authors: LISSONI P BARNI S CAZZANIGA M ARDIZZOIA A ROVELLI F BRIVIO F TANCINI G
Citation: P. Lissoni et al., EFFICACY OF THE CONCOMITANT ADMINISTRATION OF THE PINEAL HORMONE MELATONIN IN CANCER-IMMUNOTHERAPY WITH LOW-DOSE IL-2 IN PATIENTS WITH ADVANCED SOLID TUMORS WHO HAD PROGRESSED ON IL-2 ALONE, Oncology, 51(4), 1994, pp. 344-347
A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A RICCI G ALDEGHI R BRIVIO F TISI E ROVELLI F RESCALDANI R QUADRO G MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199
CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN
Authors: LISSONI P BARNI S ARDIZZOIA A OLIVINI G BRIVIO F TISI E TANCINI G CHARACIEJUS D KOTHARI L
Citation: P. Lissoni et al., CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 7(4), 1993, pp. 121-125
SEMICONDUCTOR-LASERS AND OPTICAL FEEDBACK
Authors: BRIVIO F MAZZOLENI S MILANI M
Citation: F. Brivio et al., SEMICONDUCTOR-LASERS AND OPTICAL FEEDBACK, Nuovo cimento della Societa italiana di fisica. D, Condensed matter,atomic, molecular and chemical physics, biophysics, 15(6), 1993, pp. 843-853
SUBCUTANEOUS THERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN METASTATIC GASTRIC-CANCER PATIENTS WITH LOW PERFORMANCESTATUS
Authors: LISSONI P BRIVIO F ARDIZZOIA A TANCINI G BARNI S
Citation: P. Lissoni et al., SUBCUTANEOUS THERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN METASTATIC GASTRIC-CANCER PATIENTS WITH LOW PERFORMANCESTATUS, Tumori, 79(6), 1993, pp. 401-404
IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY
Authors: LISSONI P BARNI S TANCINI G BRIVIO F CARDELLINI P VAGHI M FOSSATI V FRIGERIO F
Citation: P. Lissoni et al., IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY, Tumori, 79(4), 1993, pp. 246-249
IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEALINDOLE MELATONIN AS A NEW EFFECTIVE THERAPY IN ADVANCED CANCERS OF THE DIGESTIVE-TRACT
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A ROVELLI F CAZZANIGA M BRIVIO F PIPERNO A ALDEGHI R FOSSATI D CHARACIEJUS D KOTHARI L CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEALINDOLE MELATONIN AS A NEW EFFECTIVE THERAPY IN ADVANCED CANCERS OF THE DIGESTIVE-TRACT, British Journal of Cancer, 67(6), 1993, pp. 1404-1407
Risultati: 1-25 | 26-36 |